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Abstract 
 
Porphymonas endodontalis has been shown to populate necrotic root canal systems and 
may contribute to apical bone loss. Recent work has shown that P. endodontalis 
synthesizes a novel serine lipid class (Lipid 654) similar to that produced by P. 
gingivalis. Objective: The purpose of this study was to isolate P. endodontalis Lipid 654 
in very high purity and characterize its structure and biological activity  in RAW 264.7 
cells and HEK293 cells. Methods: P. endodontalis (ATCC 35406, type strain) was grown 
under anaerobic conditions and centrifuged. P. endodontalis total lipids were recovered 
using the Bligh and Dyer phospholipid extraction procedure and were fractionated by 
semipreparative normal phase HPLC using hexane-isopropanol-water (6:8:0.75, 
vol/vol/vol). Fractions containing Lipid 654 were identified by mass spectrometric (MS) 
analysis and were pooled, refractionated using an acidic HPLC solvent, and tested for 
biological activity. Results: MS analysis revealed that repurified Lipid 654 contained 
<0.1% contaminating lipids. TNF-α secretion from RAW 264.7 cells was promoted 
equally by both P. endodontalis and P. gingivalis Lipid 654 preparations and was 
significantly attenuated by anti-mouse TLR2 neutralizing antibody. Treatment of 
HEK293 cells, stably transfected to express TLR2 and an NFκB-dependent secretory 
alkaline phosphatase reporter, revealed that both P. endodontalis and P. gingivalis Lipid 
654 preparations engage human TLR2 with equal potency. Conclusions: Our results show 
that P. endodontalis Lipid 654 engages TLR2 with stimulation of TNF-α secretion from 
macrophages and activation of the transcription factor NF-κB, and these responses may 
contribute to apical bone destruction associated with necrotic pulps. This study was 
supported by AAE Foundation Research Grant R01 DE021055.
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Introduction and Specific Aims 
Microorganisms isolated from infected root canals are predominantly Gram-
negative and strict anaerobes (1, 2), and Porphyromonas endodontalis is frequently the 
dominant pathogen in necrotic root canals (3, 4).   P. endodontalis is thought to 
contribute to immune-activated destruction of periapical tissues through the release of 
virulence factors including lipopolysaccharide (LPS) (5-8).  However, several classes of 
biologically-active complex lipids, including phosphorylated dihydroceramides and 
serine lipids, have been shown to be produced by P. gingivalis (9-11), an organism that is 
phylogenetically related to P. endodontalis.  Of considerable interest, the serine lipids of 
P. gingivalis were recently reported to engage human and mouse Toll-like receptor 2 
(TLR2)  (11).  Furthermore, a survey of oral and intestinal organisms of the phylum 
Bacteroidetes demonstrated that all specimens produce serine lipids of the type recovered 
in P. gingivalis (11).  Because of the close phylogenetic relationship between P. 
gingivalis and P. endodontalis, the goal of this investigation was to isolate the serine lipid 
of P. endodontalis and determine whether it is structurally identical to the previously 
identified serine lipid in P. gingivalis.  Next, this investigation evaluated whether the 
serine lipid of P. endodontalis promotes activation of inflammatory cells, and whether 
these lipids can be recovered in necrotic root canals of teeth.   
 
Specific Aims: 
1. Cultivate P. endodontalis and determine whether this organism produces similar 
phosphorylated dihydroceramide lipids classes as those produced by P. gingivalis.  
1  
2. Determine whether specific lipid fractions of P. endodontalis stimulate TNF-α 
secretion from RAW 264.7 cells and engage human TLR2 receptors in HEK293 
cells, and compare these results to specific lipid fractions of P. gingivalis 
3. To quantify bacterial lipid levels in lipid extracts from pulpal tissue of extracted 
teeth 
 
Background Information 
Specific interest has been placed in the black-pigmented Gram-negative 
bacterium Porphyromonas endodontalis due to its pathogenic potential and specific 
involvement in endodontic infections (4).  P. endodontalis is a Gram-negative, obligatory 
anaerobic, non spore-forming bacterium and appears as non-motile rods or coccobacilli 
(12).  P. endodontalis is a non-fermentative anaerobic bacterium, which requires specific 
growth factors such as hemin and menadione and is extremely sensitive to oxygen (4).  
Due to these specific growth requirements, P. endodontalis cannot be easily detected by 
conventional methods and its detection in root canal infections may be underestimated 
(12). 
Although the exact mechanisms of pathogenicity of P. endodontalis are not well 
known, P. endodontalis contains several pathogenic factors (13).  The end-products of 
hemoglobin metabolism by P. endodontalis consist of n-butyric acid, acetic acid, 
hydrogen sulfide, and methyl mercaptan, which are all cytotoxic.  P. endodontalis 
produces proteases and peptidases, which are able to degrade fibrinogen, fibronectin, 
collagen type IV, and also cleave angiotensin.  A proline aminopeptidase produced by P. 
endodontalis degrades bradykinin and vasopressin.  P. endodontalis has been found to 
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elevate MMP-2 production in both human pulp and periodontal ligament (PDL) cell 
cultures.  P. endodontalis has been shown to stimulate the vascular network coincident 
with progression of inflammation through the release of vascular endothelial growth 
factor (VEGF).  In addition, P. endodontalis stimulates IL-6 production and IL-10 
production, both of which may also contribute to its inflammatory reaction (13).   
P. endodontalis, as a Gram-negative bacterium, contains lipopolysaccharide 
(LPS) in its cell wall, so much of the focus of its pathogenicity has focused on LPS.  LPS 
typically consists of a hydrophobic domain known as lipid A (or endotoxin), a non-
repeating “core” oligosaccharide, and a distal polysaccharide (or O-antigen).   LPS is 
detected by a receptor of the innate immune system present on macrophages and 
endothelial cells.  These receptors, called Toll-like Receptors (TLRs), represent a diverse 
family of molecules that play a critical role in activating the innate immune system in 
response to pathogens (11).  Two of these receptors, Toll-like receptor 4 (TLR4) and 
Toll-like receptor 2 (TLR2), have been implicated in periodontal inflammation.  TLR4 is 
a membrane-spanning protein that is distantly related to the IL1 receptor.  In 
macrophages, Lipid A activation of TLR4 triggers the biosynthesis of diverse mediators 
of inflammation, such as TNF-α and IL-1β, and activates the production of co-
stimulatory molecules required for the adaptive immune response (14).  Although Gram-
negative bacteria are generally recognized by TLR4, there is controversy regarding 
recognition of the Gram-negative bacteria because studies have shown that P. gingivalis 
can signal via TLR2, TLR4, or both (15). 
Since P. gingivalis is present in the oral cavity, researchers have examined the 
specific molecules that activate TLR receptors since they play a pivotal role in initiating 
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immune responses critical to neutralizing microbial threats to the host.  P. gingivalis has 
been associated with periodontitis primarily thought TLR2 engagement (16), and one 
consequence of the pro-inflammatory cytokines produced from TLR2 activation is the 
damaging effects on alveolar bone, resulting in bone loss as demonstrated by studies 
using TLR2-/- mice (17).  Therefore, LPS from P. gingivalis has been purified and 
examined for activation of the TLR2 receptor.  One study found that preparations of LPS 
from P. gingivalis exhibited potent TLR2, rather than TLR4 agonist activity, and to elicit 
gene expression and cytokine secretion in murine macrophages and transfectants (18).  
This has been in contrast with other studies that have shown both TLR2 and TLR4 
receptor activity by LPS isolated from enterobacteria (19, 20).   
Researchers have examined the preparations of LPS species to explain the 
differences in specific TLR activation.  It has been found that many commercial 
preparations of E. coli LPS contain low concentrations of highly bioactive contaminants.   
Using a method shown to remove endotoxin proteins from LPS preparations, the TLR 
activity of these endotoxin proteins was examined (21).  Activity was compared between 
cells from wild-type mice and cells transfected with TLR2 and TLR4 receptors.  It was 
found that the unpurified LPS was able to stimulate cells from the wild type mice that 
express TLR2 and other TLR receptors.   Eliminating endotoxin protein from LPS did not 
influence the ability to stimulate cells from wild-type mice or cells that express TLR4, 
however re-purification eliminated the ability of LPS to active cells with the TLR2 
receptor.  Additionally, the potent endotoxin protein contaminants stimulated cell lines 
with the TLR2 receptor.  These results point to the protein contaminants of LPS to be the 
active agents in stimulating the TLR2 signaling response as opposed to LPS (20). 
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Using this information, the lipids from P. gingivalis have been examined to look 
for potential contaminants that could trigger the TLR2 receptor.  P. gingivalis LPS 
prepared by the commonly used Tri-Reagent method was evaluated for contaminants 
(22).  LPS preparations were examined after additional purification approaches, including 
the Bligh and Dyer extraction procedure, were applied to remove contaminating 
phospholipids.  It was also shown, using mass spectrometric methods, that up to three 
successive ethanol washings of the Tri-Reagent-prepared LPS of P. gingivalis will 
recover significant levels of contaminating phosphorylated dihydroceramide lipids.  This 
indicates that LPS purification techniques will only partially remove phosphorylated 
dihyrdroceramide lipids from LPS, and that LPS purified by the Tri-Reagent method is 
contaminated with additional serine lipids (22). 
Using HPLC together with mass spectrometric/nuclear magnetic resonance 
spectroscopy, a new serine lipid class of P. gingivalis, Lipid 654, has been identified that 
acts as a ligand for human and mouse TLR2.  The structure of this lipid is shown below. 
 
 
 
While Lipid 654 shares all structural characteristics with the previously described lipid 5  
class termed “Flavolipin” (23, 24, 25), we have found significant differences between 
Lipid 654 and Flavolipin in biological activity.  Flavolipin was named after the organisms 
of the Flavobacterium genus from which it was originally isolated.   According to 
previous reports, Flavolipin represented approximately 20% of the total cellular lipids of 
Flavobacterium meningosepticum and was capable of acting as a TLR4 ligand (23, 25).  
In contrast, the results of our study demonstrate that Lipid 654 does not activate via 
TLR4 but rather functions as ligand for TLR2.  Since Lipid 654 acts as a TLR2 ligand but 
does not appear to activate through engagement of TLR4, it is possible that a lipid 
contaminant in the Flavolipin preparations accounted for the previously reported TLR4 
engagement (23).    
An additional important distinction between Flavolipin and Lipid 654 is that 
while only Flavobacterium species were originally reported to produce Flavolipin (23, 
24), it is reported that Lipid 654 is produced by more than Flavobacterium species.  In 
addition to P. gingivalis, analysis of lipid extracts from Prevotella intermedia, Tannerella 
forsythia, Capnocytophaga ochracea, C. gingivalis and C. sputigena revealed that each 
of these oral Bacteroidetes produce the Lipid 654 class (data not shown).  Selected 
intestinal Bacteroidetes including Prevotella copri, Parabacteroides merdea, Bacteroides 
fragilis, and B. vulgatis also produce the Lipid 654 class (data not shown).  Our evidence 
thus far indicates that Lipid 654 is produced by a wide variety of Bacteroidetes species 
and that, unlike Flavolipin, is not produced exclusively by Flavobacterium species (23, 
25).  
Using HEK293 cells stably transfected with TLR2 along with other relevant 
receptors, Lipid 654 of P. gingivalis was shown to activate human cells via TLR2.  Lipid 
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654 contains two fatty acids with one held in ester linkage (see Figure above). The Lipid 
654 class will not dissolve in aqueous solvents unless it is sonicated to form liposome 
preparations. A recent report now suggests that P. endodontalis is also capable of 
producing Lipid 654.  In the present investigation, we sought to isolate Lipid 654 from P. 
endodontalis in high purity, verify its structure and determine whether it activates human 
and mouse TLR2. 
Activation of TLR2-expressing HEK293 cells does not appear to be mediated by 
the phosphorylated dihydroceramides or phospholipid preparations of P. gingivalis.  
These other lipid classes of P. gingivalis are prominent sphingolipids that do possess 
biological activity in other cell assay systems.  These phosphorylated dihydroceramide 
lipids are important to consider because of their separation characteristics.  With normal 
phase HPLC fractionation, Lipid 654 of P. gingivalis elutes slightly earlier than the 
phosphoethanolamine dihydroceramide (PE DHC) lipids but together with 
phosphatidylethanolamine (PEA) lipids.  Though these latter two lipid classes do not 
engage TLR2, their trace but measurable contamination of the Lipid 654 class poses 
questions as to their potentiation of Lipid 654 biological effects.  With the use of state-of-
the art HPLC equipment which was not available at the time of our earlier work, the 
Lipid 654 class can now be isolated largely free of PE DHC lipids.   
It is concluded from this evidence that Lipid 654 is a structurally unique TLR2 
ligand derived from P. gingivalis.  In attempting to clarify the role of TLR2 co-receptors 
in the engagement of Lipid 654, it was observed that neutralizing antibody against either 
TLR1 or TLR6 partially inhibited HEK cell activation (data not shown), but not to the 
extent that anti TLR2 antibody inhibited HEK cell responses.  In addition, the pattern of 
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inhibition with the co-receptor antibodies appeared to differ between Lipid 654 and Lipid 
430.  Further work is needed to verify these observations.  
In unpublished studies, we have recently evaluated lipid extracts of human 
impacted third molars using Multiple Reaction Monitoring MS, specifically quantifying 
the Lipid 654 class.  It was found that these lipid extracts contain minimal amounts of 
Lipid 654 (data not shown).  These results suggest that in human tissues not directly 
exposed to bacteria, these lipids are not recovered in appreciable levels.  In contrast, 
recent studies revealed that lipid extracts from diseased human gingival tissue, carotid 
atheroma and serum, demonstrate Lipid 654 (data not shown) in levels exceeding the 
phosphorylated dihydroceramide lipids of P. gingivalis (26).  Therefore, future studies 
will focus on the recovery of 654 and 430 lipids in healthy and diseased human tissues 
including healthy and necrotic root canals of teeth. 
Although many virulence factors of P. gingivalis have been proposed to 
contribute to periodontal bone and tissue destruction (27, 28, 29), various complex lipids 
of P. gingivalis are readily detected in periodontal disease sites without concurrent 
bacterial invasion or LPS recovery (30, 31).   Further work has shown that specific lipid 
classes that are relatively minor constituents of this organism are responsible for 
activation of TLR2 and that dihydroceramide lipids are not responsible for these TLR2-
mediated biological responses.  In a study attempting to quantify the amount, Clark et al. 
determined that LPS of P. gingivalis prepared according to the methods of Yi and Hacket 
and Caroff contains an average of 3.81% by weight of lipid 654 (11). 
These results are consistent with those of other investigators who have reported 
that P. gingivalis colonization of teeth in experimental animals mediates bone loss 
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through engagement of TLR2 (28, 32, 33).  Lipid 654 produced by P. gingivalis and 
other oral Bacteroidetes may play a critical role in the development of destructive 
periodontal disease by promoting bone loss and inhibition of bone formation as 
previously reported (34).  Lipid 654 may also contribute to the development of other 
chronic inflammatory diseases of humans where these bacterial lipids accumulate in 
substantial levels due to contributions from microbes of the oral cavity, GI tract, and 
other anatomical sites.  The purpose of this investigation is to determine if Lipid 654 is 
also important in pulpal disease. 
 
Materials and Methods 
Bacterial Culture and Preparation of Lipids 
 P. endodontalis (ATCC 35406, type strain) and P. gingivalis (ATCC 33277, type 
strain) were grown in batch suspension culture under anaerobic conditions as previously 
described (9).  Bacteria were cultured in Brain Heart Infusion broth under anaerobic 
conditions and culture purity was confirmed by demonstrating uniform colony formation 
on blood agar plates.  P. endodontalis does not grow on blood agar plates when cultured 
under aerobic conditions.  Gram stain of P. endodontalis samples revealed Gram-
negative pleomorphic rods.  P. endodontalis and P. gingivalis lipids were extracted using 
the procedure of Bligh and Dyer (35) and Garbus (36).  P.  endodontalis and P. gingivalis 
lipid extracts were fractionated by high-performance liquid chromatography (HPLC) as 
previously described (9).   Replicate HPLC fractionations were pooled and evaluated 
using electrospray-mass spectrometry (ESI-MS).  ESI-MS analysis of lipid fractions was 
accomplished using an ABSciex QTrap 4000 mass spectrometer system (9, 10).   The 
9  
fractions with specific lipid components were pooled and tested for biological activity as 
described below.   The fractions containing Lipid 654 were pooled and refractionated 
using normal phase separation but with the HPLC solvent supplemented with 0.1% acetic 
acid.  Recovery of Lipid 654 and its purity were confirmed using MS analysis as 
described above. 
 
Preparation and Evaluation of Monocyte Cytokine Production 
Monocyte Raw 264.7 cells were plated at a density of 20,000 cells/well and 
treated with vehicle control, 10 µg/ml of P. endodontalis total lipid extract or 10 µg/ml of 
P. gingivalis total lipid extract in the form of sonicated liposomes.  After 24 hours, media 
samples were collected and analyzed for tumor necrosis factor-alpha (TNF-α) production 
via ELISA analysis (Duo systems, R&D systems).   The Lipid 654 fraction of P. 
endodontalis lipids was evaluated in parallel with the total lipid extracts (see below).  
Cells were also pretreated for one hour with 1 μg/ml of mouse anti-TLR2 antibody before 
treatment with Lipid 654.  Culture supernatants were collected after 24 hours of exposure 
to Lipid 654. 
Human embryonic kidney cells (HEK293 cells), transfected with either human 
TLR2 or human TLR4 and stably expressing MD-2 and CD14, were purchased from 
InvivoGen.  Cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM;Gilbco) containing 4.5 g/liter L-glucose and 10% fetal bovine serum (FBS).  The 
activities of specific TLR agonists were measured through a colorimetric assay for the 
secretory embryonic alkaline phosphatase (SEAP), a reporter gene that is linked to NF-
KB activation.  Measurement of SEAP activity using the Quanti-blue substrate 
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(InvivoGen) after TLR agonist treatment was carried out in a test medium (DMEM, 10% 
FBS) without antibiotics according to the manufacturer’s instruction.  NF-KB activation 
was expressed as a ratio for each stimulus relative to SEAP activity in unstimulated 
(vehicle control) cells.  For in vitro testing, all lipid preparations tested were solubilized 
in a 50% mixture of dimethyl sulfoxide (DMSO)-water (approximately 1.11% DMSO in 
the final culture medium).   
 
Preparation of teeth for recovery of Lipid 654 in teeth with a vital and necrotic root canal 
system. 
Recovery of Lipid 654 in pulp canals 
Extracted teeth included two basic categories of clinical samples: One type 
included teeth extracted that are confirmed by electric pulp testing to have necrotic pulpal 
contents and the other type were teeth extracted for reasons other than pulpal problems.  
The latter type of teeth were fully impacted third molars that were surgically removed by 
an Oral Surgeon.  The teeth samples were collected in compliance with the IRB approved 
protocol of the University of Connecticut Health Center.  The extracted teeth samples 
were stored frozen until processing samples in the laboratory.  The teeth were first 
cleaned of adherent soft tissue and scrubbed with household bleach.  The crown of each 
tooth was removed using a hand piece and the exposed pulp contents were reamed out 
with a bur (Peezo Reamer).  Each reamer was placed in an individual glass tube and 
lipids extracted using a chloroform:methanol lipid phospholipid extraction procedure 
described above.  The extracted lipids were analyzed for Lipid 654 using multiple 
reaction monitoring-mass spectrometry on the ABSciex QTrap 400 instrument.  This 
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mass spectrometric method quantifies the specific bacterial lipids that are thought to 
contribute to the development of pulpal disease and bone loss. 
 
Statistical Analysis 
Statistical tests included one-factor ANOVA comparing differences between 
culture treatment groups.  A Mann-Whitney U test was used to evaluate for significant 
differences between teeth with a vital pulp and teeth with a necrotic pulp.  A p value of 
less than 0.05 was considered significant for statistical comparisons. 
 
Results 
Analysis and Comparison of P. endodontalis lipids to P. gingivalis lipids 
 Identification of lipid fractions using gas chromatography-mass spectrometry 
revealed that P. endodontalis inherently produced analogous complex serine lipids when 
compared to the lipids produced by P. gingivalis (see Figure 1).   
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 Figure 1: Comparison of representative electrospray mass spectra for pooled Lipid 654 
fractions from P. endodontalis and P. gingivalis.  The serine lipids are identified in both 
bacteria, with Lipid 654 as the most abundant species within this lipid class. 
 
The major species is present with an m/z of 654 negative ion.  The serine lipids of P. 
endodontalis were identical in mass and had similar retention times on HPLC separation 
to the same lipid classes previously recovered from P. gingivalis (9).  No lipid A, which 
has an atomic mass around 1400, was observed using electrospray-mass spectrometry. 
The negative ion MS/MS analysis of the m/z 654 precursor ions revealed the 
MS/MS spectra shown in Figure 2.  
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 Figure 2: MS/MS profiles of Lipid 654 from P. endodontalis and P. gingivalis.  Identical 
ion fragments of the 654 precusor ions are identified in fractions from both P. 
endodontalis and P. gingivalis.  
 
The ion peaks are the same for Lipid 654 from P. endodontalis and P. gingivalis, which 
indicates that the precursor Lipid 654 ion has the same structure.  Using this information, 
the structure of Lipid 654 from P. endodontalis is proposed to be the same structure as 
Lipid 654 from P. gingivalis (see Figure 3). 
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Figure 3: Proposed lipid structure of P. endodontalis Lipid 654. 
 
The proposed lipid structure in Figure 3 shows the most abundant species of the Lipid 
654 class.   
 
Preparation and Evaluation of Monocyte Cytokine Production 
 RAW 264.7 cells were treated with Lipid 654 pooled from fractions of P. 
endodontalis lipids that were previously fractionated by HPLC.  These pooled fractions 
were then used to treat RAW 264.7 cells in culture.  Monocytes were also treated with 
total lipid extracts from P. endodontalis and P. gingivalis.  An untreated group served as 
the negative control, and LPS served as a positive control.  Measurements of TNF-α 
production in each group are displayed in Figure 4 below. 
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 Figure 4:  TNF-α secretion from RAW 264.7 cells was promoted by both P. endodontalis 
and P. gingivalis total lipid and Lipid 654 preparations.  This promotion was significantly 
attenuated by anti-mouse TLR2 neutralizing antibody.  Data are averaged from 3 separate 
trials. 
 
TNF-α secretion from RAW 264.7 cells was significantly promoted by both P. 
endodontalis and P. gingivalis total lipid and Lipid 654 preparations compared to control.  
Elevated TNF-α secretion was significantly attenuated by anti-mouse TLR2 neutralizing 
antibody.  The data are averaged from 3 separate trials. 
We next evaluated the biological activity dose-response characteristics of lipid 
654 from P. endodontalis and compared these responses with a well-characterized TLR2 
agonist as well as Lipid 654 from P. gingivalis for their abilities to activate TLR2-
expressing HEK293 cells.  Compared with the known TLR2 ligand positive control 
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MMP, Lipid 654 promoted HEK cell activation over the control cells (DMSO-treated 
cells) (see Figure 5).  
 
Figure 5: HEK Cell activation by P. gingivalis and P. endodontalis Lipid 654. HEK cell 
activation levels by MMP (a known TLR2 ligand), P. gingivalis Lipid 654 and P. 
endodontalis Lipid 654 were elevated compared with DMSO vehicle. 
 
MMP (molecular weight of 1,269.82) was used at a concentration of 0.2 μg/ml, or 0.158 
μM.  Lipid 654 was used at a concentration of 0.7 μg/ml representing 1.066  μM.  Results 
could not be tested for significance as only one trial was performed, but a substantial 
increase in response ratio was observed. 
Recovery of Lipid 654 in teeth with a vital and necrotic root canal system 
Ten teeth with vital pulps and ten teeth with necrotic pulps were used to evaluate 
the amount of Lipid 654 present.  Multiple Reaction Monitoring Mass Spectrometry 
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revealed the presence of Lipid 654 in all samples.  Intensity of phosphorylated 
dihydroceramides and Lipid 430 were also examined and are shown in Figures 6 and 7.  
The intensity of Lipid 654 is minimal in the tooth with a vital pulp (see Figure 6), while 
the intensity of Lipid 654 in the tooth with a necrotic pulp is much higher (see Figure 7).  
The abundance of phosphorylated dihydroceramides and Lipid 430 in teeth with vital 
pulps and teeth with necrotic pulps are similar, indicating that these lipids are not more 
abundant in teeth with necrotic pulps and likely are not heavily involved in the 
inflammatory reaction (see Figure 6 and 7).   
 
Figure 6: Multiple Reaction Monitoring of samples comparing Lipid 654 amounts in a 
tooth with a vital pulp.  The intensity of Lipid 654, phosphorylated dihydroceramides, 
and Lipid 430 is minimal in the tooth with a vital pulp. 
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 Figure 7: Multiple Reaction Monitoring of samples comparing Lipid 654 amounts in a 
tooth with a necrotic pulp.  The intensity of Lipid 654 is significantly higher than Lipid 
654 from vital pulps (see Figure 6) and phosphorylated dihydroceramides and Lipid 430, 
indicating substantially more Lipid 654 is present in teeth with necrotic pulps. 
 
Comparison of Lipid 654 levels in control teeth with vital pulps and teeth with necrotic 
pulps using multiple reaction monitoring-mass spectrometry revealed significantly more 
(P < .000001) Lipid 654 was recovered in necrotic teeth (see Figure 8).   
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 Figure 8: Comparison of Lipid 654 levels in lipid extracts from control teeth with vital 
pulps and teeth with necrotic pulps using multiple reaction monitoring-mass 
spectrometry.  The dot indicates an outlier in the control samples.  Significantly more (P 
< .000001) Lipid 654 was recovered in necrotic pulp lipid extracts (indicated by #). 
 
Outliers were observed in both the teeth with vital pulps and teeth with necrotic pulps, 
thus a Whisker plot and a Mann-Whitney U test were used to evaluate for significance. 
 
Discussion 
 
Recent studies have shown that Porphymonas species are one of the most 
prevalent bacterial species in teeth with primary and persistent apical periodontitis 
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(37,38).   Specifically, P. endodontalis has been identified in numerous studies as a 
predominant species harbored within an infected root canal space (39, 40, 41).  However, 
little is known as to how this microorganism contributes to periapical bone resorption, as 
seen in apical periodontitis.  Considerable attention has focused on specific bacterial 
components and/or by-products that are released by microorganisms into their 
surrounding environments.  A previous investigation demonstrated that exposure of 
human gingival fibroblasts to specific phospholipids of P. gingivalis significantly 
potentiated interleukin-1α (IL-1α)-mediated prostaglandin secretion and promoted 
marked changes noted in fibroblast morphology suggesting either apoptosis or necrosis 
(9).  P. endodontalis is phenotypically close to P. gingivalis and both species are 
expected to produce similar lipids.   To date, the specific serine lipid fractions produced 
by P. endodontalis have not been characterized.  By using HPLC together with mass 
spectrometric/nuclear magnetic resonance spectroscopy, we have identified a new serine 
lipid class of P. endodontalis, Lipid 654, that acts as a ligand for human and mouse 
TLR2.  
While lipid 654 shares most structural characteristics with the previously 
described lipid class that includes Flavolipin (23, 24, 25, 34) and Topostin (42), we found 
significant differences between lipid 654 and Flavolipin in their respective biological 
activities.  Flavolipin was named after the organisms of the Flavobacterium genus, from 
which it was originally isolated. According to previous reports, Flavolipin represents 
approximately 20% of the total cellular lipids of Flavobacterium meningosepticum and is 
capable of acting as a TLR4 ligand (23, 25). In contrast, the results of our study 
demonstrated that Lipid 654 does not activate via TLR4 but instead functions as a ligand 
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for TLR2. Since both lipid 654 and lipid 430 act as TLR2 ligands but do not appear to 
activate through engagement of TLR4, it is possible that a lipid contaminant in the 
Flavolipin preparations accounted for the previously reported TLR4 engagement (23). 
An additional important distinction between Flavolipin and lipid 654 is that, while 
only Flavobacterium species were originally reported to produce Flavolipin (23, 24), we 
now report that lipid 654 is produced by more than Flavobacterium species. In addition 
to P. gingivalis and P. endodontalis, analysis of lipid extracts from Prevotella intermedia, 
Tannerella forsythia, Capnocytophaga ochracea, Capnocytophaga gingivalis, and 
Capnocytophaga sputigena revealed that each of these oral Bacteroidetes produce the 
lipid 654 class (data not shown). Selected intestinal Bacteroidetes, including Prevotella 
copri, Parabacteroides merdea, Parabacteroides distasonis, Bacteroides fragilis, 
Bacteroides stercoris, Bacteroides uniformis, and Bacteroides vulgatis, also produce the 
lipid 654 class (data not shown). A complete characterization of commensal organisms 
capable of producing lipid 654 and lipid 430 will be the focus of future studies. 
Nevertheless, our evidence thus far indicates that lipid 654 is produced by a wide variety 
of Bacteroidetes species and that, unlike flavolipin, it is not produced exclusively by 
Flavobacterium species (23, 25). 
Monocyte Raw 264.7 cells were plated and treated with vehicle control, P. 
endodontalis Lipid 654 extract and P. gingivalis Lipid 654.  The Lipid 654 fraction of P. 
endodontalis lipids was evaluated in parallel with the total lipid extracts.  After 24 hours, 
a significant increase in tumor necrosis factor-alpha (TNF-α) production via ELISA 
analysis compared to control was observed for all Lipid fractions.  An increase in activity 
was observed in total lipid and Lipid 654 from P. gingivalis compared to Lipid 654 from 
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P. endodontalis.  We suspect that this may be due to the relative amount of Lipid 654 to 
lipid 430, as the amount lipid 430 may influence the activation the Monocyte Raw 264.7 
cells.  Further research is needed to evaluate the ability of Lipid 430 and Lipid 654 to 
activate Monocyte Raw 264.7 cells.  The Monocyte Raw 264.7 cells were also pretreated 
for one hour with 1 μg/ml of mouse anti-TLR2 antibody before treatment with Lipid 654.  
A significant reduction of activity by both total lipid and Lipid 654 of P. endodontalis 
was observed.  We therefore conclude from this evidence that lipid 654 is a structurally 
unique TLR2 ligand derived from P. gingivalis and P. endodontalis.  
Using HEK293 cells stably transfected with TLR2 along with other relevant 
receptors, we found that lipid 654 of P. endodontalis activates human cells via TLR2.  
Lipid 654 contains two fatty acids held in an ester linkage and will not dissolve in 
aqueous solvent unless it is sonicated to form liposome preparations.  Previous studies 
have found that activation of TLR2-expressing HEK293 cells was not mediated by the 
serine lipid preparations of P. gingivalis.  With normal-phase HPLC fractionation, Lipid 
654 of P. gingivalis and P. endodontalis elutes slightly earlier than the PE DHC lipids. 
With the use of state-of-the-art HPLC equipment, which was not available at the time of 
our earlier work, the Lipid 654 class can now be isolated largely free of PE DHC lipids.  
Since the purified PE DHC lipids demonstrate no capability to activate human cells 
through TLR2, we conclude that the previously reported activity of PE DHC lipids of P. 
gingivalis to engage TLR2 in mouse dendritic cells (43) was likely related to 
contamination of PE DHC lipids with the lipid 654 class. 
Since in vitro studies demonstrate that lipid 654 and lipid 430 activate TLR2-
expressing HEK cells, Clark et al. tested these lipids on mice to see if the same activation 
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was seen in vivo (11).  Lipid 654 or lipid 430 was injected into either wild type mice 
(WT) or TLR2-dificient mice (TRL2-/-), and the effects on serum levels of the 
chemokine CCL2 were measured 4 hours later.  CCL2, also known as monocyte chemo-
attractant protein 1, plays a major role in mediating the migration of inflammatory 
macrophages into tissue sites of inflammation.  Previous studies have demonstrated that 
administration of TLR agonists to mice can result in expression of serum CCL2, and this 
chemokine has been suggested to be important in the pathogenesis of autoimmune 
diseases.  It was observed that administration of either lipid 654 or lipid 430 to WT mice 
resulted in a significant increase in serum CCL2 levels, however in the TLR2-/- mice, 
administration of the lipid 654 or lipid 430 resulted in no increase in serum CCL2.   
These results demonstrate that both lipid 654 and lipid 430 have pro-inflammatory effects 
in vivo and that these effects are dependent on TLR2 
In this study, we evaluated lipid extracts of human impacted third molars using 
multiple reaction monitoring MS, specifically quantifying the Lipid 654 class. We found 
these lipid extracts contained minimal amounts of lipid 654 and essentially no lipid 430 
(data not shown).  These results suggest that in human tissues not directly exposed to 
bacteria, these lipids are not recovered in appreciable levels.  In necrotic pulps, a 
substantial level of Lipid 654 was recovered, suggesting that this lipid may be an 
important part of the pulpal and periapical disease process.  Worth noting is the amount 
of Lipid 430 did not increase substantially in the teeth with necrotic pulps.  Lipid 654 was 
observed in levels far exceeding the amounts seen in P. endodontalis or P. gingivalis, 
suggesting that this lipid accumulates in the pulp space of teeth with necrotic pulps.  
Recent studies revealed that lipid extracts from diseased human gingival tissue, carotid 
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atheroma, and serum demonstrate lipid 654 in levels far exceeding the phosphorylated 
dihydroceramide lipids of P. gingivalis (26).  This suggests that Lipid 654 is present in 
low levels in the blood stream, thus low amounts of Lipid 654 were observed due to the 
pulpal microvasculature.  Further research is needed to examine the production and 
activity of Lipid 430 in the necrotic pulp system. 
Although we have previously shown that LPS and lipid A of P. gingivalis are 
significantly contaminated with the phosphorylated dihydroceramide lipids (22), we have 
now determined that LPS of P. gingivalis prepared according to the methods of Yi and 
Hacket and Caroff (44, 45) contains an average 3.81% by weight of lipid 654.  LPS 
contamination with lipid 654 supports the conclusion that the TLR2 activity previously 
attributed to be LPS/lipid A of P. gingivalis (46) is due in part to the presence of the 654 
lipid class.  However, other factors could be involved, as described below.  A more recent 
report (16) indicated that the same phospholipid extraction method used in our laboratory 
(35, 36) yields an aqueous soluble factor from P. gingivalis that engages TLR2/TLR1 to a 
greater extent than the total lipids recovered in the organic solvent.  We recently 
confirmed that lipid 430 and lipid 654 can be recovered from the aqueous extract of P. 
gingivalis following acidification of the aqueous phase with acetic acid and extraction of 
lipids into chloroform.  The lipid 430 present in the aqueous phase alone could have 
produced the TLR2 effects observed by Jain et al. (16).  Jain et al. also concluded that an 
aqueous soluble TLR2/ TLR1 agonist copurifies with LPS and is released when the LPS 
is hydrolyzed to produce lipid A.  This LPS-associated factor is attenuated by lipoprotein 
lipase treatment (16).  Lipoprotein lipase will hydrolyze ester-linked fatty acids from 
triglycerides of lipoproteins.  While lipid 430 does not contain an ester-linked fatty acid, 
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the lipid 654 class does contain an ester-linked fatty acid.  Although highly purified lipid 
654 is not soluble in aqueous solvents, LPS, which is soluble in aqueous solutions and is 
contaminated with lipid 654 and lesser amounts of lipid 430 (data not shown), likely acts 
as a carrier for lipid 654 in aqueous extracts of P. gingivalis and P. endodontalis.  It is 
also possible that another TLR2 ligand or a lipoprotein that has not yet been identified is 
present in the aqueous extracts of P. endodontalis. However, the previously reported 
lipopeptide of P. gingivalis (47, 48), which is soluble in aqueous solutions, was not the 
primary TLR2/TLR1 ligand present in the P. gingivalis aqueous extract.  Until the 
putative water-soluble factor of P. gingivalis described by Jain et al. (16) is isolated and 
structurally characterized, lipid 430 and lipid 654 constitute the primary TLR2 ligands 
that are recovered in the aqueous extract of P. gingivalis.  Future work will focus on the 
water-soluble TLR2 factors produced by P. gingivalis. 
Although many virulence factors of P. gingivalis have been proposed to 
contribute to periodontal bone and tissue destruction (16, 28, 29), we have reported that 
various complex lipids of P. gingivalis are readily detected in periodontal disease sites 
without concurrent bacterial invasion or LPS recovery (30, 31).  We have now 
determined that specific lipid classes that are relatively minor constituents of this 
organism are responsible for activation of TLR2 and that dihydroceramide lipids are not 
responsible for these TLR2-mediated biological responses.  Our findings are consistent 
with those of other investigators who have reported that P. gingivalis colonization of 
teeth in experimental animals mediates bone loss through engagement of TLR2 (28, 32, 
33).  We believe that the lipid 654 and lipid 430 classes produced by P. gingivalis and 
other oral Bacteroidetes play a critical role in the development of destructive periodontal 
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disease by promoting bone loss and inhibition of bone formation, as we have previously 
reported (34). We further suggest that lipid 654 and lipid 430 may contribute to the 
development of other chronic inflammatory diseases of humans, where these bacterial 
lipids accumulate to substantial levels due to contributions from microbes of the oral 
cavity, gastrointestinal tract, and other anatomical sites. 
In summary, this investigation identified a serine lipid class produced by P. 
endodontalis that acts as a newly defined ligand for TLR2.  This lipid classes is 
comprised of a group of lipid species with a serine group, a glycine group, and amide-
linked and ester linked fatty acid side chains, and has the same structure and biological 
activity as the serine lipid previously isolated from P. gingivalis.  However, it is unclear 
at this time if the lipid species of lipid 430 represent precursor or breakdown products (or 
both) for the constituent lipid species of lipid 654, and this will be a focus of future 
investigations.  It is notable that the lipid 654 and lipid 430 classes differ substantially in 
their solubility characteristics in aqueous solvents.  We believe the different solubility 
characteristics and the enzyme susceptibilities of these lipids could provide a novel 
framework for different modes of local delivery and innate immune system activation by 
these lipids.  Thus, the two classes of lipids working together could potentially result in 
the both bone and soft tissue destruction that is associated with chronic periodontitis and 
apical periodontitis in humans. Further research will clarify these questions. 
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